Cesca Therapeutics (KOOL) Sees Large Volume Increase

Share on StockTwits

Cesca Therapeutics Inc (NASDAQ:KOOL) shares saw an uptick in trading volume on Thursday . 1,053,059 shares traded hands during trading, an increase of 281% from the previous session’s volume of 276,462 shares.The stock last traded at $0.49 and had previously closed at $0.47.

Several research firms have recently issued reports on KOOL. ValuEngine upgraded Cesca Therapeutics from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. HC Wainwright began coverage on Cesca Therapeutics in a report on Wednesday, May 23rd. They set a “buy” rating and a $1.50 price objective on the stock.

The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.79 and a current ratio of 1.61.

Cesca Therapeutics (NASDAQ:KOOL) last issued its earnings results on Thursday, March 22nd. The biotechnology company reported $0.01 earnings per share for the quarter. Cesca Therapeutics had a negative return on equity of 20.31% and a negative net margin of 56.21%. The firm had revenue of $2.94 million for the quarter. research analysts forecast that Cesca Therapeutics Inc will post -0.55 EPS for the current fiscal year.

About Cesca Therapeutics

Cesca Therapeutics, Inc engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets.

Receive News & Ratings for Cesca Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.